Nearly 4 years after medical doctors declared Marielle Santos McLeod freed from colon most cancers, she has but to really feel liberated from the burden of medical bills.
McLeod, who lives close to Charleston, South Carolina, remains to be paying off chemotherapy payments that adopted her 2017 prognosis. She additionally now faces an onslaught of out-of-pocket prices for follow-up monitoring and care, together with common visits to a pulmonologist and allergist.
McLeod, 45, mentioned she had already spent $2,500 within the first two months of the 12 months and owes an extra $1,300 from a January colonoscopy. That’s on prime of the $895 month-to-month premium for a medical insurance plan that covers her household of six.
Those prices have led McLeod to ration her different care. Despite feeling intense chest ache since February, for instance, she is pushing aside a CT scan and a go to to a coronary heart specialist.
“You’re forced to pick and choose as to where your priorities really need to be,” mentioned McLeod, director of strategic packages and partnerships on the Cancer Hope Network, a nonprofit that helps most cancers sufferers. Even in that position, she struggles to navigate the monetary aftermath of surviving the illness.
The value of postcancer care typically “keeps us hostage,” she mentioned.
McLeod is one among practically 19 million U.S. most cancers survivors, a lot of whom proceed to want prescriptions, physician visits, and procedures to observe their situation and handle posttreatment negative effects. Of greater than 1,200 most cancers sufferers and survivors surveyed in 2024, about 47% mentioned that they had carried medical debt, with practically half having owed greater than $5,000, in line with the American Cancer Society Cancer Action Network.
McLeod feels burdened by the price of colon most cancers remedy, regardless that she’s in remission. She’s nonetheless paying off chemotherapy payments that adopted her 2017 prognosis, on prime of out-of-pocket prices for follow-up monitoring and care. (Gordon McLeod)
Yet well being coverage researchers and affected person advocates mentioned the experiences of most cancers survivors reveal the boundaries of the Trump administration’s proposals to decrease premiums, which can not assist sufferers who accumulate massive medical payments 12 months after 12 months. The proposals center on increasing the availability of high-deductible health plans, which have decrease month-to-month funds however require sufferers to pay 1000’s of {dollars} out-of-pocket earlier than protection kicks in.
In addition, the administration has supported permitting insurers extra leeway to promote plans that aren’t compliant with the Affordable Care Act. Such plans may bar individuals who have preexisting well being situations, like a most cancers prognosis, and exclude essential benefits that ACA plans are required to cowl.
The administration didn’t reply a request for touch upon how its proposals would have an effect on most cancers survivors. But its supporters say, on the whole, folks would have extra flexibility to personalize protection and extra choices for plans with decrease month-to-month charges.
Michael Cannon, director of well being coverage research on the Cato Institute, a libertarian assume tank, believes sufferers would have higher management over spending, and the choice to decide on what sort of care will get coated, if well being plans have been exempted from the ACA’s rules. An individual may go for a plan that features most cancers remedy however not maternity care, for instance.
History proves insurance coverage protection shouldn’t be that straightforward, particularly for folks with preexisting situations, mentioned Jennifer Hoque, an affiliate coverage principal with the American Cancer Society Cancer Action Network. When well being plans may “pick and choose” enrollees primarily based on preexisting situations previous to the ACA, folks needing the most expensive care typically struggled to seek out protection, she mentioned.
“They’re not going to choose a cancer survivor,” Hoque mentioned of well being insurers.
Email Sign-Up
That was the case for Veronika Panagiotou, who mentioned non-public insurers refused her protection again in September 2013 as a result of she had a excessive physique mass index. Two months later, as a 25-year-old uninsured graduate pupil, she was identified with non-Hodgkin lymphoma. The hospital handled her, she recalled, “and sent me all the bills.”
In January 2014, Panagiotou was capable of purchase one of many first ACA plans that went into impact. It coated chemotherapy and immunotherapy remedy, imaging, medicines, hospital stays, weekly blood attracts, a blood transfusion, and emergency room visits.
Now Panagiotou, 37, is cancer-free and works as director of advocacy and packages at Cancer Nation, a nonprofit advocacy group. Even although she is roofed by her employer, Panagiotou mentioned treatment-related bills weigh closely on her life choices.
“Every choice I make, I think about cancer,” she mentioned.
Veronika Panagiotou was 25 years outdated and uninsured in 2013 when she was identified with non-Hodgkin lymphoma. The hospital handled her, she says, “and sent me all the bills.” Now she’s cancer-free and insured by work. But treatment-related bills nonetheless weigh closely on her life choices, she says. (Kara Kenan)
Chris Bond, a spokesperson for AHIP, the primary medical insurance commerce affiliation, mentioned its members are working to enhance entry to protection. But that may be a problem when medical doctors and drugmakers are mountain climbing costs, he mentioned. Health plans are attempting to “shield Americans from the full impact of those rising costs,” Bond mentioned.
The Lymphoma Research Foundation has seen a ten% improve in functions to its affected person support fund this 12 months, CEO Meghan Gutierrez mentioned. “This trajectory suggests that financial safety nets, when they exist, are straining,” she mentioned.
Rising costs are affecting everybody, whatever the type of medical insurance they’ve, if any, mentioned Brian Blase, president of Paragon Health Institute, a Republican-aligned assume tank. “The biggest challenge for cancer patients isn’t the type of coverage,” he mentioned. “It’s the underlying cost of care.”
Blase pointed to President Donald Trump’s focus on lowering drug prices as probably useful to most cancers survivors. The Medicare Drug Price Negotiation Program, established by the Inflation Reduction Act of 2022, required the Department of Health and Human Services to barter costs for sure high-cost medication, to decrease costs for the federal medical insurance program for folks ages 65 and older. Drugs for breast, prostate, and kidney cancers are already on that record, according to KFF.
Yet Hoque fears efforts to weaken ACA protections and monetary assist for market plans will give most cancers survivors — who she mentioned are inclined to “hang on to insurance for dear life” — fewer choices, particularly between jobs or throughout profession adjustments.
Erin Jones, a 31-year-old meals coverage researcher dwelling in Fort Collins, Colorado, who was identified with Hodgkin lymphoma as a younger grownup, is now cancer-free however nonetheless sees two oncologists, visits a high-risk breast clinic, and will get a breast MRI yearly. Jones will get medical insurance by the college the place she works, and mentioned she lately deferred acceptance to a PhD program partly as a result of uncertainty over inexpensive protection.
“I don’t have the freedom to do the things I want to do as easily,” she mentioned, “because I am constantly worried about health insurance.”
Costs associated to surviving most cancers, together with monitoring for recurrence and remedy of negative effects, have been anticipated to succeed in $246 billion by 2030, up from $183 billion in 2015, in line with research published in 2020.
Advancements in each detecting and curing most cancers have resulted in a better share of individuals surviving 5 years or extra after prognosis, in line with the American Cancer Society. The variety of survivors is predicted to develop to greater than 22 million folks by 2035, estimates show.
Despite these developments, the price of remedy can steal the highlight, mentioned Ezekiel Emanuel, a co-director of the Healthcare Transformation Institute on the University of Pennsylvania and a onetime well being coverage adviser to former President Barack Obama.
An oncologist, Emanuel mentioned he had noticed sufferers make the tough choice to delay or skip postcancer care because of this.
“Even when we triumph,” he mentioned, “we don’t seem to be able to have a celebration.”
Are you struggling to afford your medical insurance? Have you determined to forgo protection? Click here to contact KFF Health News and share your story.
